Cited by 80Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsIntracerebral and Subarachnoid Hemorrhage Research

Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress

Open access
Uekawa, Ken, Hattori, Yorito, Ahn, Sung Ji, Seo, James, Casey, Nicole, Anfray, Antoine, Zhou, Ping, Luo, Wenjie +3 more·2023·Molecular Neurodegeneration

Published version of a preprint

Abstract

Background: Cerebral amyloid angiopathy (CAA) is a devastating condition common in patients with Alzheimer’s disease but also observed in the general population. Vascular oxidative stress and neurovascular dysfunction have been implicated in CAA but the cellular source of reactive oxygen species (ROS) and related signaling mechanisms remain unclear. We tested the hypothesis that brain border-associated macrophages (BAM), yolk sac-derived myeloid cells closely apposed to parenchymal and leptomeningeal blood vessels, are the source of radicals through the Aβ-binding innate immunity receptor CD36, leading to neurovascular dysfunction, CAA, and cognitive impairment. Methods: Tg2576 mice and WT littermates were transplanted with CD36 −/− or CD36 +/+ bone marrow at 12-month of age and tested at 15 months. This approach enables the repopulation of perivascular and leptomeningeal compartments with CD36 −/− BAM. Neurovascular function was tested in anesthetized mice equipped with a cranial window in which cerebral blood flow was monitored by laser-Doppler flowmetry. Amyloid pathology and cognitive function were also examined. Results: The increase in blood flow evoked by whisker stimulation (functional hyperemia) or by endothelial and smooth muscle vasoactivity was markedly attenuated in WT → Tg2576 chimeras but was fully restored in CD36 −/− → Tg2576 chimeras, in which BAM ROS production was suppressed. CAA-associated Aβ 1-40 , but not Aβ 1-42 , was reduced in CD36 −/− → Tg2576 chimeras. Similarly, CAA, but not parenchymal plaques, was reduced in CD36 −/− → Tg2576 chimeras. These beneficial vascular effects were associated with cognitive improvement. Finally, CD36 −/− mice were able to more efficiently clear exogenous Aβ 1-40 injected into the neocortex or the striatum. Conclusions: CD36 deletion in BAM suppresses ROS production and rescues the neurovascular dysfunction and damage induced by Aβ. CD36 deletion in BAM also reduced brain Aβ 1-40 and ameliorated CAA without affecting parenchyma plaques. Lack of CD36 enhanced the vascular clearance of exogenous Aβ. Restoration of neurovascular function and attenuation of CAA resulted in a near complete rescue of cognitive function. Collectively, these data implicate brain BAM in the pathogenesis of CAA and raise the possibility that targeting BAM CD36 is beneficial in CAA and other conditions associated with vascular Aβ deposition and damage. Graphical Abstract:

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13024-023-00660-1

Cites

104 of 104 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Lipid droplet-mediated impairment of BAM phagocytosis may lead to insufficient waste clearance, causing excessive deposition of debris such as Aβ.

    “Moreover, the LD-mediated impairment of BAM phagocytosis may also lead to insufficient waste clearance at the brain interface and in the perivascular space, causing the excessive deposition of debris, such as Aβ (68, 69).”

    From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [69]

    The Discussion (page unavailable) links BAM-generated oxidative stress and neurovascular dysfunction to impaired perivascular Aβ clearance and accumulation. The Methods describe BAM phagocytosis of dextran, but the paper does not link lipid droplets or impaired BAM phagocytosis to Aβ deposition; it proposes a vascular mechanism instead. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 105 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Uekawa, K., Hattori, Y., Ahn, S. J., Seo, J., Casey, N., Anfray, A., Zhou, P., Luo, W., Anrather, J., Park, L., & Iadecola, C.
Affiliations
Weill Cornell Medicine (US)
Corresponding author
  • Park, Laibaik
  • Iadecola, Costantino
Venue
Molecular Neurodegeneration
Published
2023-10-03
Volume
18
Issue
1
Pages
73-73
ISSN
1750-1326 (ISSN-L)
OpenAlex
W4387311036
Cited by
80
References
105
Citations by year
2026: 27 · 2025: 26 · 2024: 25 · 2023: 2
FWCI
14.21
Type
journal article
Language
en
Open access
Locations
  • Molecular Neurodegeneration (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (NS37853)
  • National Institute of Health (NS097805)
  • Japan Heart Foundation/Bayer Research Grant Abroad
  • The Uehara Memorial Foundation Research Fellowship
  • Japan Society for the Promotion of Science Overseas Research Fellowships
  • Leon Levy Foundation
  • BrightFocus Foundation
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Neurology › Intracerebral and Subarachnoid Hemorrhage Research
Keywords
cerebral amyloid angiopathy, border-associated macrophages, CD36, reactive oxygen species, vascular oxidative stress, neurovascular dysfunction, Aβ40, cognitive impairment, Alzheimer's disease, bone marrow transplantation, functional hyperemia, cerebral blood flow, amyloid-beta clearance, Tg2576 mice, innate immunity, perivascular macrophages

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review